image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

InnovaDerma

April 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • IDP
  • Price:
  • 125.5p
The shares fell sharply after InnovaDerma warned that while the second half will significantly outperform the first, revenue growth will be lower than anticipated at the time of its interim results, which themselves showed a small loss of £30,000 on revenues that rose 31% to £4.2m. That had been caused by one off product launch costs and new staff to support international growth.The bugbear for the second half slow-down has been lower than expected orders placed by Superdrug (its largest account c. 45% of group sales) for Skinny Tan, despite the brand’s continued growth.The company’s direct to consumer platform for Skinny Tan is performing well and in line, with the group also engaged in discussions wi ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X